AstraZeneca reported that the Court of Appeals for the Federal Circuit has upheld a decision of the U.S. District Court in Delaware that the substance patent protecting its cholesterol-lowering drug Crestor is "valid and enforceable.
SoloHealth reported that its SoloHealth Station health and wellness kiosk has seen consumer engagement surge over 200% since late summer. The company said Thursday that to date nearly 5 million consumers have interacted with the health screening kiosk, up from 2.5 million in late August.
Elite Pharmaceuticals Inc. has shored up its supply of phentermine active ingredient for the next year. The company said Thursday that it has in place an agreement with the its sole supplier of the active pharmaceutical ingredient for its product lines that include phentermine HCl tablets (37.
Markwins International has completed its purchase of Physicians Formula Holdings Inc., a deal valued at about $75 million. Markwins said Wednesday that it has acquired all of the outstanding stock of Physicians Formula for $4.90 per share in cash.
The Emerson Group has named Clark Tyndall, Sue Smith and Brian Schaefer as new partners. The consumer products consulting and services firm said Tuesday that Tyndall, Smith and Schaefer will join its Partner Group.
Acura Pharmaceuticals Inc. has launched Nexafed, a nasal decongestant with a technology that disrupts the conversion of pseudoephedrine into the dangerous drug methamphetamine. Nexafed uses Acura’s Impede technology, which disrupts the extraction and conversion of pseudoephedrine to methamphetamine.
PepsiCo has entered wide-ranging global partnership singing superstar and model Beyoncé that the beverage giant said marks a new way that it teams with musical artists. Under the deal, Beyoncé will have her image on Pepsi can slated to debut in 2013.
Meda has signed an agreement to acquire MidNite, a over-the-counter sleeping aid. The Sweden-based company said Friday that the MidNite brand is well-established in the United States and holds a market-leading position in an expanding category. Marketed by Concepts In Health Inc.
This month, Mars Chocolate North America plans to roll out a special edition of M&M’s with colors picked solely by fans.
Oral care brand Abreva is teaming up with Olympic volleyball gold medalist Misty May-Treanor in a campaign to dispell myths about cold sores.
AmerisourceBergen Corp. has named Peyton Howell as a corporate senior vice president and as president of global sourcing and manufacturer relations. The pharmaceutical distributor said Wednesday that Howell assumes the new post immediately.
Ocean Global has introduced DiVertigo, an all-natural, over-the-counter remedy for vertigo symptoms.
AstraZeneca is kicking off a program with more than 26,000 national, regional and independent pharmacies to ramp up retail availability of Brilinta, an anticoagulant. The drug maker said Tuesday that the U.S.
Naterra International Inc. has begun the national launch of Phase+, a skin care line designed to address the cosmetic effects that diabetes has on the skin.
Seven months after becoming chief executive officer, Alex Gorsky has been elected as chairman of the board at Johnson & Johnson. J&J said Friday that current chairman Bill Weldon, Gorsky’s predecessor as CEO, is slated to step down on Dec. 28 and to retire early next year after a brief transitional
Mylan Inc. has been cleared by the Food and Drug Administration to market tolterodine tartrate tablets (1 mg and 2 mg), a bladder medication. The company said Thursday that the product, which is shipping immediately, is a generic version of Pharmacia and Upjohn’s Detrol tablets.
